|
US20040208875A1
(en)
*
|
1995-03-15 |
2004-10-21 |
Queen's University At Kingston |
Method for treating amyloidosis
|
|
US5840294A
(en)
*
|
1993-03-29 |
1998-11-24 |
Queen's University At Kingston |
Method for treating amyloidosis
|
|
GB9610829D0
(en)
*
|
1996-05-23 |
1996-07-31 |
Medical Res Council |
Screening of agents for treatment of azlheimers disease
|
|
DK1014996T3
(da)
*
|
1997-08-28 |
2003-09-29 |
Univ Washington |
Præparater indeholdende saccharid til behandling af Alzheimers sygdom og andre amyloidoser
|
|
AU2006228064C1
(en)
*
|
1998-02-11 |
2009-01-29 |
Bhi Limited Partnership |
Method for modulating macrophage activation
|
|
US20020022657A1
(en)
*
|
1998-02-11 |
2002-02-21 |
Francine Gervais |
Methods for modulating neuronal cell death
|
|
AU2437899A
(en)
*
|
1998-02-11 |
1999-08-30 |
Neurochem, Inc. |
Method for modulating macrophage activation
|
|
US6329356B1
(en)
|
1998-04-10 |
2001-12-11 |
Neurochem, Inc. |
Phosphono-carboxylate compounds for treating amyloidosis
|
|
EP1077690A1
(en)
*
|
1998-05-15 |
2001-02-28 |
Neurochem, Inc. |
Use of amyloid inhibitors for modulating neuronal cell death
|
|
AU2006203051C1
(en)
*
|
1998-05-15 |
2009-01-22 |
Bhi Limited Partnership |
Use of amyloid inhibitors for modulating neuronal cell death
|
|
EP1609467A1
(en)
*
|
1998-07-28 |
2005-12-28 |
Neurochem (International) Limited |
Compositions for treating diseases associated with glycosaminoglycan-associated molecular interactions
|
|
US6310073B1
(en)
*
|
1998-07-28 |
2001-10-30 |
Queen's University At Kingston |
Methods and compositions to treat glycosaminoglycan-associated molecular interactions
|
|
KR20070094996A
(ko)
*
|
1999-04-28 |
2007-09-27 |
뉴로겜 인터내셔널 리미티드 |
아밀로이드증 치료용 조성물 및 방법
|
|
AU2005203635B2
(en)
*
|
1999-05-24 |
2008-08-07 |
Bellus Health (International) Limited |
Methods and compounds for inhibiting amyloid deposits
|
|
US6562836B1
(en)
*
|
1999-05-24 |
2003-05-13 |
Queen's University Of Kingston |
Methods and compounds for inhibiting amyloid deposits
|
|
HK1051137A1
(zh)
*
|
1999-07-09 |
2003-07-25 |
Isis Innovation Limited |
抑制疾病的化合物和製備移植用的細胞
|
|
US6310048B1
(en)
|
1999-12-09 |
2001-10-30 |
St. Louis University |
Antisense modulation of amyloid beta protein expression
|
|
KR20080003945A
(ko)
|
1999-12-23 |
2008-01-08 |
뉴로겜 인터내셔널 리미티드 |
대뇌 아밀로이드 혈관병증을 조절하는 화합물 및 방법
|
|
JP2005231998A
(ja)
*
|
2000-02-01 |
2005-09-02 |
Zeria Pharmaceut Co Ltd |
透析アミロイド線維重合核の製造方法及び透析アミロイド−シス治療剤のスクリーニング方法並びに透析アミロイドーシス治療剤
|
|
US7311893B2
(en)
*
|
2000-07-25 |
2007-12-25 |
Neurochem (International) Limited |
Amyloid targeting imaging agents and uses thereof
|
|
US20020115717A1
(en)
*
|
2000-07-25 |
2002-08-22 |
Francine Gervais |
Amyloid targeting imaging agents and uses thereof
|
|
US20070208087A1
(en)
|
2001-11-02 |
2007-09-06 |
Sanders Virginia J |
Compounds, compositions and methods for the treatment of inflammatory diseases
|
|
JP2005504053A
(ja)
*
|
2001-08-31 |
2005-02-10 |
ニューロケム （インターナショナル） リミテッド |
アミロイドーシス治療のためのアミジン誘導体
|
|
WO2003089460A1
(en)
|
2002-04-19 |
2003-10-30 |
The Governing Council Of The University Of Toronto |
Immunological methods and compositions for the treatment of alzheimer's disease
|
|
SI2527315T1
(sl)
*
|
2002-05-31 |
2014-06-30 |
Proteotech Inc., |
Spojine, sestavki in metode za zdravljenje amiloidnih bolezni in sinukleinopatij, kot so Alzheimerjeva bolezen, diabetes tipa 2 in Parkinsonova bolezen
|
|
US20040057949A1
(en)
*
|
2002-09-23 |
2004-03-25 |
Depaolis Potito U. |
Hemodialysis method for improving immune system function
|
|
US20050031651A1
(en)
*
|
2002-12-24 |
2005-02-10 |
Francine Gervais |
Therapeutic formulations for the treatment of beta-amyloid related diseases
|
|
JP2006512417A
(ja)
*
|
2002-12-24 |
2006-04-13 |
ニューロケム （インターナショナル） リミテッド |
β−アミロイド関連疾患の治療のための治療用製剤
|
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
|
US7521481B2
(en)
|
2003-02-27 |
2009-04-21 |
Mclaurin Joanne |
Methods of preventing, treating and diagnosing disorders of protein aggregation
|
|
WO2005000295A1
(en)
*
|
2003-05-20 |
2005-01-06 |
Transtech Pharma, Inc. |
Rage antagonists as agents to reverse amyloidosis and diseases associated therewith
|
|
US7244764B2
(en)
*
|
2003-06-23 |
2007-07-17 |
Neurochem (International) Limited |
Methods and compositions for treating amyloid-related diseases
|
|
US7414076B2
(en)
*
|
2003-06-23 |
2008-08-19 |
Neurochem (International) Limited |
Methods and compositions for treating amyloid-related diseases
|
|
AU2011250847B2
(en)
*
|
2003-06-23 |
2013-06-20 |
Bhi Limited Partnership |
Methods and compositions for treating amyloid-related diseases
|
|
HRP20140442T1
(hr)
*
|
2003-06-23 |
2014-07-04 |
Kiacta Sàrl |
Metoda za pripremu spoja 1,3-propan disulfonske kiseline
|
|
US7253306B2
(en)
|
2003-06-23 |
2007-08-07 |
Neurochem (International) Limited |
Pharmaceutical drug candidates and methods for preparation thereof
|
|
US20070010573A1
(en)
*
|
2003-06-23 |
2007-01-11 |
Xianqi Kong |
Methods and compositions for treating amyloid-related diseases
|
|
US20050142191A1
(en)
*
|
2003-06-23 |
2005-06-30 |
Neurochem (International) Limited |
Pharmaceutical formulations of amyloid inhibiting compounds
|
|
CA2528627A1
(en)
*
|
2003-06-23 |
2005-01-06 |
Neurochem (International) Limited |
Treatment of protein aggregation disorders
|
|
US20060079578A1
(en)
*
|
2003-06-23 |
2006-04-13 |
Julie Laurin |
Pharmaceutical formulations of amyloid inhibiting compounds
|
|
CA2529256A1
(en)
*
|
2003-06-23 |
2004-12-29 |
Neurochem (International) Limited |
Methods and compositions for treating amyloid-related diseases
|
|
CA2529269C
(en)
*
|
2003-06-23 |
2012-02-07 |
Neurochem (International) Limited |
Improved pharmaceutical drug candidates and methods for preparation thereof
|
|
US7262223B2
(en)
*
|
2004-01-23 |
2007-08-28 |
Neurochem (International) Limited |
Amidine derivatives for treating amyloidosis
|
|
WO2005077382A1
(ja)
*
|
2004-02-17 |
2005-08-25 |
National Institute Of Advanced Industrial Science And Technology |
プリオン増殖抑制剤
|
|
WO2005095633A1
(en)
*
|
2004-04-02 |
2005-10-13 |
Queen's University At Kingston |
A cell culture system for modelling serum amyloid a amyloidogenesis and identifying amyloid modulating compounds
|
|
WO2006059252A2
(en)
*
|
2004-11-12 |
2006-06-08 |
Neurochem (International) Limited |
Methods and fluorinated compositions for treating amyloid-related diseases
|
|
US20060167057A1
(en)
*
|
2004-11-16 |
2006-07-27 |
Xianqi Kong |
Compounds for the treatment of CNS and amyloid associated diseases
|
|
CA2588423A1
(en)
*
|
2004-11-17 |
2006-05-26 |
Joanne Mclaurin |
Compositions comprising scyllo-inositol derivatives and methods to treat disorders of protein aggregation
|
|
BRPI0519243A2
(pt)
|
2004-12-22 |
2009-01-06 |
Neurochem Int Ltd |
mÉtodos e composiÇÕes para tratar doenÇas relacionadas a amilàide
|
|
KR20070120190A
(ko)
*
|
2005-04-12 |
2007-12-21 |
뉴로켐 (인터내셔널) 리미티드 |
아밀로이드 억제 화합물의 제약 제제
|
|
TW200716088A
(en)
*
|
2005-04-15 |
2007-05-01 |
Neurochem Int Ltd |
Formulations and methods for treating amyloidosis
|
|
CA2609980C
(en)
*
|
2005-05-27 |
2015-10-13 |
Queen's University At Kingston |
Treatment of protein folding disorders
|
|
WO2007023389A2
(en)
*
|
2005-07-21 |
2007-03-01 |
Neurochem (International) Limited |
Polymorphic forms of 3-amino-1-propanesulfonic acid
|
|
JP2009510050A
(ja)
*
|
2005-09-30 |
2009-03-12 |
ベルス ヘルス （インターナショナル） リミティッド |
カルボキシアルキルスルホン酸を含む薬学的組成物および方法
|
|
CA2626005A1
(en)
*
|
2005-10-13 |
2007-10-25 |
Waratah Pharmaceuticals Inc. |
Inositol derivatives and their uses in the treatment of diseases characterized by abnormal protein folding or aggregation or amyloid formation, deposition, accumulation or persistence
|
|
CN101506236B
(zh)
|
2005-11-30 |
2012-12-12 |
雅培制药有限公司 |
抗淀粉样β蛋白的单克隆抗体及其用途
|
|
RU2442793C2
(ru)
|
2005-11-30 |
2012-02-20 |
Эбботт Лэборетриз |
АНТИТЕЛА ПРОТИВ ГЛОБУЛОМЕРА Аβ, ИХ АНТИГЕНСВЯЗЫВАЮЩИЕ ЧАСТИ, СООТВЕТСТВУЮЩИЕ ГИБРИДОМЫ, НУКЛЕИНОВЫЕ КИСЛОТЫ, ВЕКТОРЫ, КЛЕТКИ-ХОЗЯЕВА, СПОСОБЫ ПОЛУЧЕНИЯ УКАЗАННЫХ АНТИТЕЛ, КОМПОЗИЦИИ, СОДЕРЖАЩИЕ УКАЗАННЫЕ АНТИТЕЛА, ПРИМЕНЕНИЯ УКАЗАННЫХ АНТИТЕЛ И СПОСОБЫ ИСПОЛЬЗОВАНИЯ УКАЗАННЫХ АНТИТЕЛ
|
|
MX2008008213A
(es)
*
|
2005-12-22 |
2008-09-03 |
Neurochem Int Ltd |
Tratamiento de trastornos renales, nefropatia diabetica y dislipidemias.
|
|
EP1976495A2
(en)
*
|
2006-01-06 |
2008-10-08 |
Aarhus Universitet |
Compounds acting on the serotonin transporter
|
|
US20070197452A1
(en)
*
|
2006-02-17 |
2007-08-23 |
Mclaurin Joanne |
Treatment of amyloid-related diseases
|
|
CN103054837A
(zh)
*
|
2006-03-09 |
2013-04-24 |
瓦拉塔药品公司 |
用于治疗蛋白积聚病症的环己烷多元醇制剂
|
|
US20110028719A1
(en)
*
|
2006-05-19 |
2011-02-03 |
Jacek Slon-Usakiewicz |
Screening methods for amyloid beta modulators
|
|
US20100173960A1
(en)
*
|
2006-09-21 |
2010-07-08 |
Antonio Cruz |
The Combination of a Cyclohexanehexol and a NSAID for the Treatment of Neurodegenerative Diseases
|
|
MX339684B
(es)
|
2006-10-12 |
2016-06-06 |
Bhi Ltd Partnership |
Metodos, compuestos, composiciones y vehiculos para suministrar el acido 3-amino-1-propanosulfonico.
|
|
EP2091566A4
(en)
*
|
2006-11-24 |
2011-07-06 |
Waratah Pharmaceuticals Inc |
COMBINATION THERAPIES AGAINST ALZHEIMER DISEASE AND SIMILAR ILLNESSES
|
|
US8455626B2
(en)
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
|
MX2009006768A
(es)
*
|
2006-12-22 |
2009-08-31 |
Bellus Health Int Ltd |
Metodos, compuestos, y composiciones para tratar trastornos metabolicos y diabetes.
|
|
JP2010513219A
(ja)
*
|
2006-12-22 |
2010-04-30 |
ベラス ヘルス （インターナショナル） リミテッド |
腎臓の疾患、糖尿病性腎症及び脂質代謝異常の治療
|
|
EP2124952A2
(en)
|
2007-02-27 |
2009-12-02 |
Abbott GmbH & Co. KG |
Method for the treatment of amyloidoses
|
|
AR060412A1
(es)
*
|
2007-04-10 |
2008-06-18 |
Creactivar S A |
Una composicion farmaceutica utilizable para inhibir o evitar la formacion no deseada de tejido fibroso y uso de la n- sulfoetilnicotinamida para inhibir o evitar la formacion no deseada de tejido fibroso
|
|
AR060411A1
(es)
*
|
2007-04-10 |
2008-06-18 |
Creactivar S A |
Una composicion farmaceutica utilizable en el tratamiento o prevencion de una enfermedad pulmonar y uso de la n-sulfoetilnicotinamida en el tratamiento o prevencion de dicha enfermedad
|
|
CA2683546A1
(en)
*
|
2007-04-12 |
2008-10-23 |
Joanne Mclaurin |
Use of cyclohexanehexol derivatives in the treatment of .alpha.-synucleinopathies
|
|
US20100144891A1
(en)
*
|
2007-04-12 |
2010-06-10 |
Mclaurin Joanne |
Use of cyclohexanehexol derivatives in the treatment of amyotrophic lateral sclerosis
|
|
HRP20130768T1
(en)
*
|
2007-04-12 |
2013-10-25 |
Waratah Pharmaceuticals, Inc. |
Use of cyclohexanehexol derivatives in the treatment of ocular diseases
|
|
US20110105626A1
(en)
*
|
2007-04-12 |
2011-05-05 |
Mclaurin Joanne |
Use of cyclohexanehexol derivatives for the treatment of polyglutamine diseases
|
|
US8613923B2
(en)
|
2007-06-12 |
2013-12-24 |
Ac Immune S.A. |
Monoclonal antibody
|
|
US8048420B2
(en)
|
2007-06-12 |
2011-11-01 |
Ac Immune S.A. |
Monoclonal antibody
|
|
RU2482876C2
(ru)
|
2007-10-05 |
2013-05-27 |
Дженентек, Инк. |
Применение антитела против амилоида-бета при глазных заболеваниях
|
|
CA2740124A1
(en)
*
|
2008-10-09 |
2010-04-15 |
Waratah Pharmaceuticals Inc. |
Use of scyllo-inositols for the treatment of macular degeneration-related disorders
|
|
WO2011017800A1
(en)
|
2009-08-10 |
2011-02-17 |
Bellus Health (International) Limited |
Methods, compounds, and compositions for delivering 1,3-propan ed isulfonic acid
|
|
CN107260740A
(zh)
*
|
2009-09-17 |
2017-10-20 |
比斯普科生物科学有限公司 |
N‑2‑羟基‑乙基‑哌嗪‑n’‑2‑乙磺酸(hepes) 在疼痛控制和脱髓鞘损伤逆转中的作用
|
|
WO2011041198A1
(en)
|
2009-09-30 |
2011-04-07 |
Transtech Pharma, Inc. |
Substituted imidazole derivatives for treatment of alzheimers disease
|
|
KR101173677B1
(ko)
*
|
2009-12-11 |
2012-08-13 |
한국과학기술연구원 |
Ｅｐｐｓ를 유효성분으로 함유하는 베타아밀로이드 집적 관련 질환의 예방 또는 치료용 약학적 조성물
|
|
US8987419B2
(en)
|
2010-04-15 |
2015-03-24 |
AbbVie Deutschland GmbH & Co. KG |
Amyloid-beta binding proteins
|
|
CN103179981B
(zh)
|
2010-07-30 |
2017-02-08 |
Ac免疫有限公司 |
安全和功能性的人源化抗β‑淀粉样蛋白抗体
|
|
CN103298833B
(zh)
|
2010-08-14 |
2015-12-16 |
Abbvie公司 |
β淀粉样蛋白结合蛋白
|
|
US9717710B2
(en)
|
2012-10-05 |
2017-08-01 |
Vtv Therapeutics Llc |
Treatment of mild and moderate Alzheimer's disease
|
|
US11077095B2
(en)
|
2017-02-24 |
2021-08-03 |
Alzheon, Inc. |
Methods for treating neurodegenerative disorders
|
|
CN114805211B
(zh)
|
2017-03-21 |
2024-08-23 |
润佳（苏州）医药科技有限公司 |
同位素富集3-氨基-1-丙磺酸衍生物、药物组合物及其用途
|
|
CN109394746A
(zh)
*
|
2017-08-15 |
2019-03-01 |
江西青峰药业有限公司 |
乙基硫酸铵在制备用于预防或治疗炎症性疾病药物中的应用
|
|
WO2019190822A1
(en)
|
2018-03-28 |
2019-10-03 |
Vtv Therapeutics Llc |
Crystalline forms of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1h-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine
|
|
WO2019190823A1
(en)
|
2018-03-28 |
2019-10-03 |
Vtv Therapeutics Llc |
Pharmaceutically acceptable salts of [3-(4- {2-butyl-1-[4-(4-chlorophenoxy)-phenyl]-1h-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine
|
|
PT3829568T
(pt)
*
|
2018-08-01 |
2023-12-14 |
Alzheon Inc |
Derivados de ácido sulfopropanoico para tratamento de distúrbios neurodegenerativos
|
|
MX2021001287A
(es)
*
|
2018-08-01 |
2021-07-15 |
Alzheon Inc |
Métodos para tratar trastornos neurodegenerativos.
|
|
EP3864008A1
(en)
|
2018-10-10 |
2021-08-18 |
vTv Therapeutics LLC |
Metabolites of [3-(4-{2-butyl-l-[4-(4-chloro-phenoxy)-phenyl]-lh-imidazol-4-yl } -phen ox y)-prop yl] -diethyl-amine
|
|
CN112791078B
(zh)
|
2019-11-13 |
2022-12-06 |
润佳（苏州）医药科技有限公司 |
同位素富集的3-氨基-1-丙磺酸及其衍生物的用途
|